‘It is time to stop admiring the problem’

SHPA welcomes patient-focused recommendations in rare cancers Senate report, noting the PBS currently fails many patients The Society of Hospital Pharmacists of Australia (SHPA) says it welcomes the release of the Senate report into equitable access to diagnosis and treatment for individuals with rare and less common cancers, including neuroendocrine cancer. The report, available here,